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INTRODUCTION
Polysaccharides are natural occurring polymers that play important roles in our immune system, e.g. in cellular recognition processes and pathogen infections. Sugar binding proteins, so called lectins are often overexpressed on the surface of antigen presenting cells (APC) and can interact with sugar ligands, (for example like those expressed on bacterial cell walls) and trigger or regulate immune responses. 1, 2 In recent years this specific interaction has stimulated the interest in glycomimetic materials with improved therapeutic efficiencies. 3, 4 Synthetic glycopolymers have been demonstrated to be superior oligosaccharide mimics because they enable the incorporation of multiple saccharides along a polymer backbone and thus amplification of carbohydrate-lectin/cell interactions, 5, 6 also known as the cluster glycoside effect. 7 To date, diverse polymerization techniques have been exploited for the synthesis of defined glycopolymers, [8] [9] [10] [11] [12] including but not limited to, reversible deactivation radical polymerizations (RDRPs), ring-opening metathesis polymerization (ROMP), and ring-opening polymerizations (ROPs). The self-assembly of glycopolymers or the surface modification of particles with sugar units give rise to even more sophisticated materials, namely glycoparticles, which not only show carbohydrate-specific interactions but additionally exploit the beneficial physiochemical properties of particulate systems. [13] [14] [15] To date, a wide range of glycosylated carriers has been fabricated, such as micelles, polymersomes, and metallic, magnetic, and self-assembled nanoparticles.
Preferential uptake of particles by specific types of antigen presenting cells (APCs) such as dendritic cells (DCs), macrophages (MACs) or myeloid derived suppressor cells (MDSCs), can lead to different immune responses and eventually different therapeutic outcomes. Uptake by DCs is usually a key step to induce adaptive immune responses, and has been a major focus of synthetic vaccine development for infectious diseases and cancer. 16, 17 By contrast, uptake by MACs or MDSCs can lead to either activation or conversely suppression of immune responses, and is being explored to develop therapeutics against autoimmune and allergic diseases. 18 The state of activation of the APCs and the type of surface molecules that they upregulate after interacting with particles, will also influence their ability to activate or suppress immune responses. In this context, MACs and MDSCs that express high levels of the programmed death ligand 1 (PDL1) have high capacity to turn off immunity by interacting with programmed death 1 (PD1) molecules present on diverse immune cells such as T cells and NK cells. 19 By contrast, 4 activated mature DCs that express high levels of molecules that allow them to effectively interact with T cells, such as CD80, are classically strong activators of immunity. 20 Herein, we explore the balance of preferential uptake of glycomimetic layer-by-layer (LbL) microparticles by DCs compared with MACs and MDSCs, as well as the potential change in key regulatory molecules CD80 and PDL1 on these different APC subsets.
Poly(2-oxazoline)s (POx) are an emerging polymer class, 21 which have attracted significant attention in the biomaterials area 22, 23 since they combine excellent biocompatibility [24] [25] [26] [27] and protein repellence properties 28 along with the ease of synthesizing highly functional materials. [29] [30] [31] [32] Recently, we reported the LbL assembly of POx-based systems for the fabrication of lowfouling, redox-and enzyme-degradable and targeted hollow polymer capsules. [33] [34] [35] The LbL approach 36, 37 has attracted increasing interest for the engineering of particulate delivery systems, 38, 39 as it allows tailoring of the physical and chemical properties of the carriers.
Previously, particular focus was placed on the design of brush-like POx by RDRPs as they allow for the incorporation of further functional groups that are beneficial for covalent or reversible cross-linking and labelling or modification with targeting units of the capsules post-assembly.
Copper-catalyzed alkyne-azide cycloaddition (CuAAc) 33, 35 and dynamic thiol-disulfide exchange reactions 34 were employed depending on the desired application, for example for the modification of the capsule surface with a phage-display derived single-chain antibody (scFv) for the specific targeting of activated platelets. 35 Other interesting targeting ligands that are readily available are mono-and disaccharides. Over the last decade, a range of glycopoly(2-oxazoline)s has been reported using glycosylated 2-oxazoline monomers 40 or post-polymerization reactions such as thiol-ene chemistry. [41] [42] [43] An elegant approach for the synthesis of glycosylated brush-like POx was reported by Weber et al. using telechelic POx macromonomers with α-sugar and ω-methacrylate end groups. 44 In this work, we demonstrate the fabrication of LbL assembled glycopoly(2-oxazoline)-based capsules. To the best of our knowledge, the formation of hollow multilayered capsules by hydrogen-bonded LbL of glycopolymers has not yet been reported. The glycopolymer was obtained by a combination of living/controlled polymerization techniques and highly efficient post-polymerization modifications. Alkyne functionalities introduced during this process were then exploited for the modification with mannose moieties, labeling and multilayer crosslinking.
The mannosylated films and capsules showed specific interactions with the lectin concanavalin by which these molecules are controlled was further explored by the use of fluorescently labeled microparticles, providing evidence for the existence of two mechanisms: cytokine independent cis-activation for CD80 up-regulation specifically on DCs, and broad trans-downregulation of PDL1 across multiple cell types (balanced against particle uptake induced up-regulation). by CROP of 2-ethyl-2-oxazoline (EtOx) initiated with methyl tosylate and terminated with methacrylic acid (Scheme S1). 45 The copolymerization of OEtOxMA with glycidyl methacrylate (GMA) by ATRP yielded highly functional copolymers (PEtOxMAGMA), which can be efficiently modified through ring-opening reaction with nucleophiles. In this way, brush-like PEtOx with pendant alkyne moieties were prepared (PEtOxMAAlk), which were further functionalized with mannose azide in a CuAAC reaction to yield PEtOxMAMan. ).
Multilayer Assembly on Planar and Particle Supports. Quartz crystal microbalance (QCM)
and flow cytometry were used to monitor the assembly of PEtOxMAAlk/PMA and PEtOxMAMan/PMA multilayer films via hydrogen bonding, respectively. Polymer solutions were prepared at 1 mg mL -1 (50 mM NaOAc, pH 4) and five PEtOxMAx/PMA bilayers were iteratively deposited. For QCM studies, an additional PEI (1 mg mL -1 , 0.5 M NaCl) layer was 8 initially deposited onto the gold surface of the QCM crystal prior to the layer buildup. PMA was allowed to adsorb for 15 min before washing the film in NaOAc buffer. Subsequently, PEtOxMAx was adsorbed for 20 min followed by the next washing step. This procedure was repeated four more times. The formation of hydrogen-bonded PEtOxMAx/PMA multilayer films was confirmed by a frequency decrease with increasing number of polymer layers ( Figure S2A ).
The deposition of the PEtOxMAMan/PMA bilayer system showed only a slightly higher frequency change compared to the PEtOxMAMan/PMA bilayer system, suggesting a similar hydrogen-bonding interaction of both systems.
To examine the multilayer film formation on particle supports, PEtOxMAx and AF488-cadaverine labeled PMA (PMA488) were deposited alternatively onto monodisperse SiO2 particles (1.16 µm in diameter) at pH 4. The particles were incubated in the respective polymer solutions for 15 min before washing them via three centrifugation/re-dispersion cycles, as detailed in the Experimental Section. After the deposition of each bilayer the fluorescence intensity of the core/shell particles was measured by flow cytometry. For both bilayer systems a regular and linear layer buildup was observed ( Figure S2B ) similarly to the QCM studies.
Scheme 2. Preparation of PEtOxMAAlk and PEtOxMAMan capsules via hydrogen-bonded LbL
assembly of PEtOxMAAlk (non-mannosylated) or PEtOxMAMan (mannosylated) and PMA.
For the fabrication of hollow mannosylated and non-mannosylated polymer capsules, five
PEtOxMAMan/PMA and PEtOxMAAlk/PMA bilayers, respectively, were deposited onto monodisperse SiO2 particles (1.16 µm) and cross-linked with a non-degradable bisazide crosslinker similar to a procedure reported for other CuAAC "click" capsules previously (Scheme 2). 46 Remaining alkyne groups in the multilayer films were further modified with azide- Glycopolymers or glycopolymer assemblies are capable of multivalent binding to lectins, a process known as the "cluster-glycoside effect". 7 Concanavalin A (ConA) is a lectin, which specifically binds to mannosyl and glucosyl residues. ConA possesses four binding sites, which enable the binding of up to four sugar groups resulting in protein aggregation when a multivalent carbohydrate or glycopolymer is employed. PEtOxMAMan capsules assessed by fluorescence microscopy. Scale bar = 5 µm.
QCM measurements were performed to provide evidence of the binding of the glycopolymer films to ConA. To this end, the gold surfaces of the QCM chips were coated with PEI and PMAAlk. The latter was used to deposit PEtOxMAAlk and PEtOxMAMan via hydrogen bonding interaction, respectively, and stabilize the film at physiological pH using CuAAC chemistry.
Upon exposure of the PEtOxMAMan film to ConA, a significant decrease in frequency was observed. In contrast, the PEtOxAlk film showed only marginal frequency changes (Figure 3a ). Capsule uptake by different APC subsets. All capsule types, regardless of surface modification by mannose, showed preferential uptake by stimulatory rather than inhibitory APC subsets. Hence, as shown in Figure 5 , capsules were preferentially internalized by conventional DCs (CD11c+Gr1-), MACs (CD11c-Gr1-,) and then by MDSCs (CD11c-Gr1+) after 18 h coculture. The effect was titratable, with more cells taking up capsules at higher capsule doses. PEtOxMAAlk capsules did not induce CD80 expression on any cell type tested. In contrast, PEtOxMAMan capsules showed large and significant increases in CD80 expression on DCs compared to the other groups, including the treatment group with soluble PEtOxMAMan at an equivalent concentration to that present on the capsules. To further determine whether CD80 upregulation was due to a direct (cis) interaction between the capsules and DCs or to an indirect (trans) effect mediated by soluble cytokines, we analyzed the cells which had either internalized or not internalized the capsules in the same culture. Figure 6B shows clearly that only DCs that had taken up capsules (Cap+ cells) also up-regulate CD80 expression.
PDL-1 is an important negative modulator of immune function, and is associated with a tolerogenic DC phenotype. 47 Expression of PDL-1 was determined on the three types of APC cell types studied after treatment with the control LPS, soluble PEtOxMAMan, PEtOxMAAlk and PEtOxMAMan capsules. LPS treatment significantly increased PDL-1 expression ( Figure 6C ) in all cell types studied (DCs, MDSCs and MACs). By contrast, high doses of capsule particles decreased PDL-1 expression on DCs across the cultures, independent of the type of capsule. An analysis of cells that had taken up capsules compared to those that did not, revealed PDL-1 downregulation on DCs in the absence of particle uptake, suggesting significant trans effects for PDL-1 downregulation ( Figure 6D ). By contrast, overall PDL-1 expression, found also preferentially on DCs was highest on cells that had taken up particles, consistent with uptake induced upregulation. 
EXPERIMENTAL PART

Materials and Instrumentation
Silica particles (1.16 μm) were purchased from MicroParticles GmbH (Germany) as a 5 wt% suspension and were used as received. Poly(methacrylic acid, sodium salt) (PMA, 30 wt%), Mw 15 kDa, was purchased from Polysciences (USA). 2-Ethyl-2-oxazoline, methyl tosylate, and triethylamine were purchased from Sigma-Aldrich, distilled to dryness and stored under argon. 
Poly(oligo(2-ethyl-2-oxazoline methacrylate)-stat-glycidyl methacrylate) (PEtOxMAGMA):
PEtOxGMA was prepared by atom transfer radical polymerization (ATRP). OEtOxMA (1 g; 2 mmol) and PMDETA (19.9 mg; 0.11 mmol) were dissolved in anisole (3 mL) and degassed for 30 min. In parallel, GMA (187.4 mg; 1.32 mmol) and EBIB (6.5 mg; 0.033 mmol) were dissolved in anisole (1 mL), CuBr (15.5 mg; 0.11 mmol) was added and the suspension was 
Post-polymerization modification of PEtOxMAGMA with propargylamine (PEtOxMAAlk).
PEtOxGMA (150 mg; 0.0085 mmol), propargylamine (76 mg; 1.37 mmol) and triethylamine (138 mg; 1.37 mmol) were dissolved in dry DMSO (2 mL) and the solution was stirred at 50 °C overnight. Subsequently, the solvent was removed under reduced pressure. The polymer was redissolved in methanol and dialyzed against methanol for 1 day and subsequently against Milli-Q for 2 days (MWCO = 3.5 kDa). PEtOxMAAlk was recovered by freeze-drying. To follow the assembly of multilayers on particle supports fluorescently labeled PMA (PMA488) was used for the buildup to monitor the sequential assembly with flow cytometry. PEtOxMAx and PMA488 were alternately adsorbed onto 100 µL silica particles (5 wt%, 1.16 µm-diameter), as described above, until 5 bilayers were deposited (i.e., PMA as the terminating layer) onto the particle supports. After each adsorption step, the core-shell particles were re-suspended in 20 μL NaOAc (20 mM, pH 4) and a 3 µL sample of the particles was taken and analyzed using the flow cytometer.
Crosslinking of the Multilayers: After completion of the assembly and extensive washing, the core-shell particles were re-dispersed in 0.5 mL NaOAc (20 mM, pH 4) and incubated in 600 µL 
Generation of bone marrow derived DC, MAC and MDSC cultures in vitro
Bone marrow cells from femurs and tibias of C57BL/6 mice (n=2) were collected and treated with ACK lysis buffer (155 mM NHCl4, 10 mM Na-EDTA, 100 mM KHCO3 pH 7.2) for 3-5 minutes at room temperature to lyse erythrocytes. Cells were pooled, washed and cultured at 5 x 
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